Biologic drugs during COVID-19 outbreak

Int J Dermatol. 2020 Oct;59(10):1293. doi: 10.1111/ijd.15088. Epub 2020 Aug 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biological Products / adverse effects*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / prevention & control
  • Comorbidity
  • Confounding Factors, Epidemiologic
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / epidemiology
  • Dermatitis, Atopic / immunology
  • Female
  • Hidradenitis Suppurativa / drug therapy*
  • Hidradenitis Suppurativa / epidemiology
  • Hidradenitis Suppurativa / immunology
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Pandemics / prevention & control
  • Psoriasis / diagnosis
  • Psoriasis / drug therapy*
  • Psoriasis / epidemiology
  • Psoriasis / immunology
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • Severity of Illness Index
  • Young Adult

Substances

  • Biological Products